Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Schizophrenia Bulletin · 04.07.2023 · 49 (4) · 962-972
DOI: 10.1093/schbul/sbad030 ↗Kurz gefasst
Leitlinie in der Zeitschrift Schizophrenia Bulletin, online erschienen am 21.03.2023. Verfasst von Elias Wagner und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Clozapine, Psychotic Disorders. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHMRC Investigator Grant Emerging Leadership.
Abstract (Originalsprache)
Background and Hypothesis There is limited evidence to guide the approaches to clozapine treatment. Accordingly, an international initiative was undertaken with the aim of developing consensus recommendations for the optimization of clozapine monotherapy. Study Design We conducted an online Delphi survey among members of the Treatment Response and Resistance in Psychosis (TRRIP) working group comprising experts from twenty-nine countries. The threshold criterion for a consensus recommendation was ≥ 75% agreement (“agree” and “strongly agree” responses) on a question. Agreement of ≥ 50% but < 75% in a second or third Delphi round was deemed to provide guidance. Study Results Forty-nine (first round), 32 (second round), and 48 (third round) of the 91 current TRRIP members participated. Expert recommendations at ≥ 75% comprised second-line treatment with clozapine in cases of persistent positive symptoms with co-occurring extrapyramidal symptoms, tardive dyskinesia, or suicidality/aggression. There was considerable disagreement on myocarditis screening parameters. The management of somatic and neuropsychiatric adverse drug reactions warrants further research for more evidence-based recommendations. Rechallenge with clozapine was recommended for eosinophilia, sinus tachycardia and fever and guidance (agreement ≥ 50%) was reached for pneumonia and thrombocytopenia. Conclusions Given the limited evidence available, this consensus-based series of recommendations and guidance statements supports clinical decision-making to optimize clozapine monotherapy and provides guidance for future research in treatment-resistant schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
- Department of Psychiatry, School of Medicine, University of Queensland, Brisbane, Australia.
- Mobile Intensive Rehabilitation Team, Metro South Addiction and Mental Health Service, Brisbane, Australia.
- Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
- Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
- Institute for Behavioral Science, Feinstein Institute for Medical Research, Manhasset, NY, USA.
ORCID-Profile: Jimmy Lee, Emilio Fernandez-Egea
Förderung
- NHMRC Investigator Grant Emerging Leadership
Zitieren
APA
Wagner, E., Siskind, D., Falkai, P., Howes, O., Correll, C., Lee, J., Honer, W. G., Kane, J. M., Fernandez-Egea, E., Barnes, T. R. E., Hasan, A., & TRRIP Working Group (2023). Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. Schizophrenia Bulletin, 49(4), 962-972. https://doi.org/10.1093/schbul/sbad030
Vancouver
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, et al. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. Schizophrenia Bulletin. 2023;49(4):962-972. doi:10.1093/schbul/sbad030
BibTeX
@article{Wagner2023,
author = {Wagner, Elias and Siskind, Dan and Falkai, Peter and Howes, Oliver and Correll, Christoph and Lee, Jimmy and Honer, William G and Kane, John M and Fernandez-Egea, Emilio and Barnes, Thomas R E and Hasan, Alkomiet and TRRIP Working Group, TRRIP Working Group},
title = {Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group},
journal = {Schizophrenia Bulletin},
year = {2023},
volume = {49},
number = {4},
pages = {962--972},
doi = {10.1093/schbul/sbad030}
}
EUVIMED